• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利南北地区肌萎缩侧索硬化症死亡证明的准确性差异显著:对死亡率研究的影响。

Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.

作者信息

Ragonese Paolo, Filippini Graziella, Salemi Giuseppe, Beghi Ettore, Citterio Antonietta, D'Alessandro Roberto, Marini Carmine, Monsurrò Maria Rosaria, Aiello Isidoro, Morgante Letterio, Tempestini Antonella, Fratti Cesare, Ragno Michele, Pugliatti Maura, Epifanio Antonio, Testa Daniela, Savettieri Giovanni

机构信息

Institute of Neuropsychiatry, University of Palermo, Palermo, Italy.

出版信息

Neuroepidemiology. 2004 Jan-Apr;23(1-2):73-7. doi: 10.1159/000073978.

DOI:10.1159/000073978
PMID:14739571
Abstract

OBJECTIVE

To evaluate the accuracy of death certificates (DCs) for amyotrophic lateral sclerosis (ALS) in different parts of Italy. Studies based on DC diagnosis for ALS have shown a reduced mortality comparing northern with southern Italy. These data are in contrast with results from other surveys on the incidence of ALS performed in Italy and other countries.

METHODS

Archives of neurological clinics from northern (Milano, Monza, Pavia, and Bologna) and southern Italy including islands (Napoli, Sassari, Palermo, and Messina) were searched for patients discharged with a diagnosis of ALS in the period 1970-1995. Subjects affected by definite/probable ALS according to the Scottish Motor Neuron Disease Research Group diagnostic criteria were included. DCs were obtained from the vital statistic bureau. True positive rates (TPRs) and 95% confidence intervals (CIs) for proportions were calculated for northern and southern Italy separately. Multiple logistic regression analysis was performed according to gender, age at onset, age and year of death, and interval between onset and death.

RESULTS

We found 651 patients affected by definite/probable ALS; 573 of them had died by December 31, 1996. DCs were available for 566 subjects (411 from northern Italy and 155 from southern Italy). TPR was 66.7% (95% CI 61.9-71.2) for northern Italy and 51.6% (95% CI 43.5-59.7) for southern Italy (chi(2) = 10.9, p = 0.001). Logistic regression analysis showed an association between a lower accuracy of DCs and the interval between onset of symptoms and death. TPR calculations considering different death periods (1970-1982 and 1983-1996) showed comparable rates of accuracy over time.

CONCLUSIONS

Mortality statistics based on official death records do not accurately reflect interregional mortality for ALS in Italy.

摘要

目的

评估意大利不同地区肌萎缩侧索硬化症(ALS)死亡证明的准确性。基于死亡证明诊断ALS的研究显示,意大利北部与南部相比死亡率较低。这些数据与在意大利和其他国家进行的关于ALS发病率的其他调查结果形成对比。

方法

检索意大利北部(米兰、蒙扎、帕维亚和博洛尼亚)和包括岛屿在内的南部(那不勒斯、萨萨里、巴勒莫和墨西拿)神经科诊所的档案,查找1970 - 1995年期间诊断为ALS出院的患者。纳入根据苏格兰运动神经元疾病研究组诊断标准确诊为明确/可能ALS的患者。从生命统计局获取死亡证明。分别计算意大利北部和南部的真阳性率(TPR)及比例的95%置信区间(CI)。根据性别、发病年龄、死亡年龄和年份以及发病与死亡之间的间隔进行多因素逻辑回归分析。

结果

我们发现651例明确/可能患有ALS的患者;其中573例在1996年12月31日前死亡。566名受试者有死亡证明(411名来自意大利北部,155名来自意大利南部)。意大利北部的TPR为66.7%(95% CI 61.9 - 71.2),意大利南部为51.6%(95% CI 43.5 - 59.7)(χ² = 10.9,p = 0.001)。逻辑回归分析显示死亡证明准确性较低与症状出现至死亡之间的间隔有关。考虑不同死亡时期(1970 - 1982年和1983 - 1996年)的TPR计算显示,随着时间推移准确率相当。

结论

基于官方死亡记录的死亡率统计不能准确反映意大利各地区ALS的死亡率。

相似文献

1
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies.意大利南北地区肌萎缩侧索硬化症死亡证明的准确性差异显著:对死亡率研究的影响。
Neuroepidemiology. 2004 Jan-Apr;23(1-2):73-7. doi: 10.1159/000073978.
2
The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy.意大利雷焦艾米利亚肌萎缩侧索硬化症的流行病学
Amyotroph Lateral Scler. 2008 Dec;9(6):350-3. doi: 10.1080/17482960802196150.
3
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis.肌萎缩侧索硬化症死亡证明诊断的准确性。
J Epidemiol Community Health. 1992 Oct;46(5):517-8. doi: 10.1136/jech.46.5.517.
4
Incidence of ALS in Lombardy, Italy.意大利伦巴第地区肌萎缩侧索硬化症的发病率。
Neurology. 2007 Jan 9;68(2):141-5. doi: 10.1212/01.wnl.0000250339.14392.bb.
5
Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy.意大利南部巴勒莫省运动神经元病和多发性硬化症死亡证明的准确性。
Neuroepidemiology. 2002 May-Jun;21(3):148-52. doi: 10.1159/000054812.
6
Epidemiology of amyotrophic lateral sclerosis.肌萎缩侧索硬化症的流行病学
Adv Neurol. 1982;36:281-302.
7
Epidemiology of ALS in Italy: a 10-year prospective population-based study.意大利肌萎缩侧索硬化症的流行病学:一项基于人群的10年前瞻性研究。
Neurology. 2009 Feb 24;72(8):725-31. doi: 10.1212/01.wnl.0000343008.26874.d1.
8
Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study.乌拉圭肌萎缩侧索硬化症的发病率和患病率:一项基于人群的研究。
Neuroepidemiology. 2008;30(2):105-11. doi: 10.1159/000120023. Epub 2008 Mar 11.
9
Incidence of amyotrophic lateral sclerosis in Sicily: A population based study.西西里岛肌萎缩侧索硬化症的发病率:一项基于人群的研究。
Amyotroph Lateral Scler. 2012 May;13(3):284-7. doi: 10.3109/17482968.2012.662689. Epub 2012 Mar 13.
10
Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.肌萎缩侧索硬化症患者诊断延迟及进入临床试验的预测因素:一项基于人群的研究。
J Neurol Sci. 2006 Dec 1;250(1-2):45-9. doi: 10.1016/j.jns.2006.06.027. Epub 2006 Aug 22.

引用本文的文献

1
A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes.职业运动员和大学生运动员患神经退行性疾病和神经认知障碍的风险的系统评价。
Neurol Sci. 2022 Dec;43(12):6667-6691. doi: 10.1007/s10072-022-06319-x. Epub 2022 Aug 17.
2
Analysis of incidence of motor neuron disease in England 1998-2019: use of three linked datasets.1998-2019 年英格兰运动神经元病发病率分析:三个关联数据集的应用。
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug;23(5-6):363-371. doi: 10.1080/21678421.2021.2016837. Epub 2022 Feb 1.
3
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.
确诊肌萎缩侧索硬化症病例队列中的生存情况及死因
PLoS One. 2015 Jul 14;10(7):e0131965. doi: 10.1371/journal.pone.0131965. eCollection 2015.
4
Encephalitis-associated hospitalizations among American Indians and Alaska Natives.美国印第安人和阿拉斯加原住民的脑炎相关住院情况。
Am J Trop Med Hyg. 2014 Apr;90(4):755-9. doi: 10.4269/ajtmh.13-0420. Epub 2014 Feb 10.
5
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.肌萎缩侧索硬化症:2013 年的最新临床特征、病理生理学、管理和治疗试验。
Aging Dis. 2013 Oct 1;4(5):295-310. doi: 10.14336/AD.2013.0400295.
6
Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis.法国运动神经元病死亡率变化(1968-2007):一项年龄-时期-队列分析。
Eur J Epidemiol. 2011 Sep;26(9):729-37. doi: 10.1007/s10654-011-9595-0. Epub 2011 Jun 15.
7
Validating population-based registers for ALS: how accurate is death certification?基于人群的 ALS 登记验证:死亡证明的准确性如何?
J Neurol. 2010 Aug;257(8):1235-9. doi: 10.1007/s00415-010-5494-7. Epub 2010 Feb 12.
8
Association of lead exposure with survival in amyotrophic lateral sclerosis.铅暴露与肌萎缩侧索硬化症患者生存率的关联
Environ Health Perspect. 2008 Jul;116(7):943-7. doi: 10.1289/ehp.11193.
9
Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data.通过运动神经元疾病死亡率数据看肌萎缩侧索硬化症的地理分布。
Eur J Epidemiol. 2007;22(11):781-90. doi: 10.1007/s10654-007-9173-7. Epub 2007 Sep 14.